News Kits Eyecare Ltd.

Equities

KITS

CA49804N1042

Delayed Toronto S.E. Other stock markets 01:55:32 2024-04-25 pm EDT			5-day change	1st Jan Change
5.71 ^CAD	+1.06%		-8.64%	-8.49%

Apr. 16	KITS Eyecare Ltd. Announces Executive Appointments	CI
Apr. 10	Kits Eyecare Announces Sabrina Liak Will Transition to Senior Advisor Role and Continue as Board Member	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

KITS Eyecare Sets First Quarter 2024 Conference Call for Wednesday, May 8, 2024, at 9:00 a.m. ET	Apr. 23	AQ
KITS Eyecare Hires Two Key Senior Finance Leaders	Apr. 16	AQ
KITS Eyecare Ltd. Announces Executive Appointments	Apr. 16	CI
Kits Eyecare Announces Sabrina Liak Will Transition to Senior Advisor Role and Continue as Board Member	Apr. 10	MT
KITS Eyecare Announces Sabrina Liak will Transition to Senior Advisor Role and Continue as Board Member	Apr. 10	AQ
Kits Eyecare Reporting Preliminary Q1 Results	Apr. 04	MT
KITS Eyecare Brief: Revenue Grew Approximately 23% YOY to Over $34 Million; Cash Position Remains Strong at Approximately $18 Million	Apr. 04	MT
KITS Eyecare Brief: Reporting Preliminary First Quarter 2024 Results	Apr. 04	MT
KITS Eyecare Reports Preliminary First Quarter 2024 Results	Apr. 04	AQ
KITS Eyecare to Present at the LD Micro Invitational XIV	Apr. 02	NE
Kits Eyecare Promotes Zhe Choo to Chief Financial Officer Role	Mar. 18	MT
KITS Eyecare Names Zhe Choo Chief Financial Officer	Mar. 18	AQ
KITS Eyecare Brief: Naming Zhe Choo Chief Financial Officer	Mar. 18	MT
Kits Eyecare Ltd. Appoints Zhe Choo as Chief Financial Officer, Effective March 31, 2024	Mar. 18	CI
KITS Eyecare to Participate in the 36th Annual ROTH Conference on March 18, 2024	Mar. 12	AQ
Transcript : Kits Eyecare Ltd., Q4 2023 Earnings Call, Mar 06, 2024	Mar. 06
Kits Eyecar Narrows Q4 Loss, Revenue Grows	Mar. 06	MT
Kits Eyecare Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
KITS Eyecare Brief: Q4 Net loss improved to $0.5 million, or $(0.02) per share (basic), compared to a net loss of $1.4 million, or $(0.04) per share (basic), in the prior year period	Mar. 06	MT
KITS Eyecare Brief: Q4 Revenue increased by 21% to a record $31.7 million compared to $26.2 million	Mar. 06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Kits Eyecare Ltd.

Equities

KITS

CA49804N1042

Summary

Filters